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Abstract
This report describes the optimization and evaluation of a simple single-step lysis protocol to measure luciferase
bioluminescence from genetically modified Plasmodium falciparum. This protocol utilizes a modified commercial
buffer to improve speed of assay and consistency in the bioluminescence signal measured by reducing the
manipulation steps required to release the cytoplasmic fraction. The utility of this improved assay protocol is
demonstrated in typical assays that explore absolute and temporal gene expression activity.
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Background
The use of reporter assay systems in the human malarial
parasite Plasmodium falciparum have proven an invalu-
able tool in the functional characterization of cis-acting
sequences that govern the promoter and terminator
activities of gene flanking sequences [1-3]. The two
most commonly used reporter systems utilize either a
bacterial chloramphenicol acetyltransferase (cat) gene or
a Photinus pyralis luciferase (luc) gene [4,5]. Both assay
systems offer attractive properties in terms of sensitivity
and large linear range for quantification of activity. The
non-isotopic bioluminescence assay provided by luc,
however, offers additional attributes such as speed of
assay (no need for lengthy incubations for the end-point
of the cat assay), easier handling and waste disposal
characteristics, and ability to exploit recent advances in
instrumentation for the detection of bioluminescence.
One final advantage of the luc assay, its flexibility, has
recently been evidenced in the malarial field by the
development of a high throughput anti-malarial drug
screening assay using transgenic parasites expressing luc
[6-9].
There are, however, inherent limitations in the utiliza-
tion of the luc reporter assay system. Whilst valuable in
demonstrating the effect of modified gene flanking
sequences in determining the absolute level of gene
expression, the concatamerization of episomal plasmids,
unequal segregation of plasmids during mitotic division,
and frequent use of mis-matched 5’ and 3’ gene flanking
sequences, limit their use in the exploration of molecu-
lar mechanisms that govern temporal patterns of gene
expression [1,10]. These limitations, however, can be
mitigated by the use of matched 5’ and 3’ flanking
sequences in combination with the bxb1 integrase sys-
tem to ensure production of homogenous populations
of parasites that each contain a single reporter gene cas-
sette [11,12]. However, the repeated lysis and washing
steps required to produce a cleared parasite cytoplasmic
fraction from the intraerythrocytic stages of parasite
development often generate a variation in the biolumi-
nescence signal that needs to be carefully controlled
(typically through cell count and protein concentration
quantification). This variation is particularly confound-
ing when attempting a multi-variant analysis, resulting
in data that may demonstrate a trend but falls short of
demonstrating significance.
Here the optimization and validation of a modified
luciferase reporter gene assay protocol for the asexual
intraerythrocytic stages of P. falciparum is described.
This revised protocol uses a simple single-step lysis pro-
tocol with an improved lysis buffer formulation to gen-
erate a more consistent bioluminescent signal output.
* Correspondence: p.d.horrocks@keele.ac.uk
1Institute for Science and Technology in Medicine, Keele University,
Staffordshire ST5 5BG, UK
Full list of author information is available at the end of the article
Hasenkamp et al. Malaria Journal 2012, 11:42
http://www.malariajournal.com/content/11/1/42
© 2012 Hasenkamp et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.The utility of this modified assay is demonstrated by
showing its ease of use in generating a comprehensive
portrait of temporal gene expression and how consis-
tency in data can provide significant information from a
multi-variant promoter deletion study where previously
only trends had been described.
Methods
Plasmodium falciparum clones and culture
The genetically modified P. falciparum clone expressing
luciferase (Pfluc) used here has previously been
described [12]. This clone was originally derived from
the AHE1 clone (Dd2
attB) using the mycobacteriophage
bxb1 integration system [11,12]. In Pfluc, the luc repor-
t e rg e n ei sf l a n k e db y1 4 1 7b pa n d6 4 7b po f5 ’ and 3’
flanking sequences, respectively of Pfpcna (PF13_0328).
Clones Δ2a n dΔ3c o n t a i n1 1 6 0b pa n d9 9 0b po f5 ’
Pfpcna flanking sequence, respectively [12]. All clones
were cultured under standard conditions (complete
growth medium, 2% haematocrit, atmosphere of 1% O2,
3% CO2,a n d9 6 %N 2) and maintained using 5 nM
WR99210 and 2.5 μg/ml BSD (blasticidin S) drug selec-
tion [11]. Staging and parasitaemia was determined by
Giemsa-stained thin blood smears and light microscopy.
Synchronization of cultures was attained using sequen-
tial sorbitol treatment [13].
Standard reporter lysis assay
Plasmodium falciparum-infected erythrocytes (IE) were
collected by centrifugation (5 min, 3000xg, RT) and 20
μl samples of packed IE lysed using 10 volumes of 1×
phosphate buffered saline (PBS)/0.1% saponin at room
temperature for 5 min. Following centrifugation, the
parasite pellet was washed three times in 1× PBS and
re-suspended in 100 μl of 1× Reporter Lysis Buffer (Pro-
mega), and subjected to three cycles of freeze (liquid
nitrogen) and thaw (37°C) with a final centrifugation
step of 13000 rpm for 2 min to clear the parasite super-
natant. Bioluminescence readings were measured using
the single-tube luminometer (Glomax 20/20, Promega)
from 20 μl of cleared parasite supernatant and 100 μlo f
Luciferase Substrate Reagent (Promega).
Statistics
Analysis for significance in the bioluminescent signals
determined for the reporter deletion series was carried
out using n = 6 independent measurements for each
construct at each developmental stage and analysed
using one-way analysis of variants (ANOVA), with
Tukey’s post tests for significance, on MiniTab version
14. All other experiments were carried out using n = 5
independent measurements. Where indicated, t-tests
were carried out in GraphPad Prism version 5.0 (Graph-
Pad Software, San Diego California USA).
Results
Evaluation of parameters for a simplified single-lysis step
luciferase reporter assay
The standard luciferase reporter assay protocol for P.
falciparum requires release of the parasite from the host
erythrocyte, extensive washing of the parasite pellet to
remove haemoglobin, and then a repeated process of
freeze-thaw lysis of the parasite to release the cytoplas-
mic fraction [5,12]. This protocol was devised prior to
the improved performance and sensitivity of modern
luminometers and it was reasoned that a revaluation of
the lysis conditions should be explored in an attempt to
simplify the protocol to use only a single lysis step.
Throughout this study, a standard of five repeats of 20
μl of packed trophozoite-IE were prepared to investigate
each set of parameters under investigation. Following
lysis, 20 μl of IE or isolated-parasite supernatant frac-
tions were mixed with 100 μl of luciferase assay sub-
strate (Promega, UK) and the bioluminescent signal
measured for 10 sec using a Glomax 20/20 luminometer
(Promega). The signals obtained from the standard lysis
protocol were initially compared with those from a sin-
gle-step lysis of IE using a commercially available repor-
ter lysis buffer (RLB, Promega, UK). Here, packed IE
were re-suspended in a range of pellet volumes of 1 ×
RLB (1, 2.5, 5 and 10-fold pellet volumes), mixed using
a bench-top vortex and incubated at room temperature
for 5 min. A 20 μl volume of IE supernatant was then
removed for detection of the bioluminescent signal. This
single-step lysis protocol is thus dramatically less com-
plex and time-consuming than the previous standard
protocol, which typically takes 30-45 min. Whilst the
standard lysis protocol, irrespective of the volumes of
RLB used, always generated a higher bioluminescent sig-
nal, the variation in signal obtained for the four matched
samples was high; such that no significant difference
could be determined between each of the conditions
u s e d( F i g u r e1 A ) .T h i si si nm a r k e dc o n t r a s tw i t ht h e
improvement in consistency of bioluminescent signal
derived using the simpler single-step lysis protocol;
where a significant difference in all pair-wise compari-
son was determined (t-test, p < 0.05).
To explore the possibility of improving the biolumi-
nescent signal obtained using the single-step lysis proto-
col, two variables were explored. First was the use of
different lysis buffers, and second the pellet-volume of
lysis buffer used. A range of commercial lysis buffers
optimized for bioluminescence assays are available; here
the performance of the previously used RLB was com-
pared against cell culture lysis reagent (CCLR, Promega,
UK) and passive lysis buffer (PLB, Promega, UK), in
each case assessing its use in the presence or absence of
a 0.1% saponin supplement. Using five-pellet volumes (i.
e. 100 μl) of each lysis buffer, the bioluminescent
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pared to a control using the standard lysis protocol and
a five-pellet volume of RLB (Figure 1B). Saponin was
observed to significantly enhance the bioluminescent
signal obtained using all lysis buffers (t-test, p < 0.005).
Comparison of the bioluminescent signal using the dif-
ferent buffers shows a clear preference for the modified
PLB/0.1% saponin buffer. A revised assay was thus
adopted using this modified buffer as the data would
indicate that some 65% of the bioluminescent signal lost
on adoption of the single-step assay can be recovered
without adversely compromising the consistency of the
data produced.
To explore the effect of the pellet-volume of lysis buf-
f e ru s e d ,t h es a m et r o p h o z o i t es t a g eP f l u cI Ec u l t u r e
was subjected to single-step lysis using between 2-15
fold pellet volumes of PLB/0.1% saponin. As 20 μlo fI E
supernatant is used to measure bioluminescence, this
signal output was normalized for an equivalent number
of parasites to account for the dilution attributed to the
use of different volumes of lysis buffer across the experi-
ment. This normalization reveals a slight hyperbolic
curve (near linear, r
2 = 0.90) relationship between the
bioluminescent signal per standardised parasite number
and the volume of lysis buffer, suggesting that larger
buffer volumes are more efficient in releasing luciferase
from the IE pellet (Figure 2A). Saturation of the biolu-
minescent signal was only consistently achieved using in
excess of 20-pellet volumes of PLB/0.1% saponin (data
not shown). Given this near linear relationship over the
fold-volumes explored here and consideration of the
cost/benefit of complete lysis and dilution of biolumi-
nescent signal when using large volumes of this com-
mercial reagent; five volumes of PLB/0.1% saponin
would appear to balance these competing variables and
was taken forward for all subsequent studies described
here.
The final step in the validation of the revised single-
step lysis protocol was a demonstration that the biolu-
minescent signal generated is directly proportional to
the number of parasites being assayed. A range of differ-
ent volumes of Pfluc IE (2-16 μl) were subject to single-
step lysis using PLB/0.1% saponin and the biolumines-
cent signal plotted against parasite number (Figure 2B).
To explore the effect of haemoglobin from uninfected
and infected erythrocytes on this relationship, the
volume of the IE pellet was made up to 20 μlu s i n g
either phosphate-buffered saline (PBS) or packed unin-
fected erythrocytes (uIE). The bioluminescent signal
obtained from IE supplemented with uIE was, in all
cases, significantly less than that when supplemented
with PBS. Plotting the bioluminescence signal against a
linear scale of the number of parasites, reveals a strong
correlation between IE number and signal for both con-
ditions; with trend lines that would appear to be conver-
ging as the total number of erythrocytes (uIE and IE)
becomes equivalent. This presumably reflects the known
quenching effect of haemoglobin on luciferase
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Figure 1 Comparison of performance of the standard and single-step lysis protocols.( A)T h em e a na n ds t d e v( n=5 )o ft h er e l a t i v e
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however, this revised single-step lysis protocol produces
a bioluminescent signal directly proportional to the
number of parasites irrespective of the presence of hae-
moglobin and would indicate that washing away of hae-
moglobin is not required.
Demonstrating the utility of a single-step lysis protocol to
investigate absolute and temporal changes in gene
expression
The luc reporter gene in Pfluc is flanked by 1417 bp and
6 4 7b po f5 ’ and 3’ flanking sequences, respectively, of
the Pfpcna (PF13_0328) gene [12]. Pfpcna encodes the
proliferating cell nuclear antigen, a protein essential for
efficient DNA polymerase δ activity during S-phase.
These flanking sequences have previously been demon-
strated to be sufficient to completely reconstitute the
trophozoite-specific temporal pattern of intraerythrocy-
tic expression of Pfpcna over the luc reporter gene
[12,15,16]. Previous analysis of the temporal pattern of
luciferase expression in Pfluc, however, was focussed on
a small number of samples harvested only from major
morphological stages of intraeythrocytic development.
The ease of use of the single-step lysis protocol was
exploited here to facilitate a more comprehensive analy-
sis of the temporal profile of luciferase expression across
a full cycle of IE development (Figure 3). Over a 51 h
period, samples were harvested at 14 time points from a
starting culture of tightly synchronized ring-stage Pfluc.
As expected, the onset of the Pfpcna-mediated biolumi-
nescent signal was linked to the development of early
trophozoite stage parasites and peaked in mature tro-
phozoites; entirely coincident with the expected demand
for Pfpcna during schizogony [12,15]. The expression
levels start to subside as morphological evidence of schi-
zogony is evident, with the bioluminescent signal essen-
tially absent in the re-invaded rings. Comparison of the
temporal luciferase reporter gene activity with the tem-
poral pattern of Pfpcna steady-state mRNA levels (Fig-
ure 3 inset), available from microarray assays [17], show
the previously described correlation between steady-
state mRNA levels and luciferase expression, providing
comprehensive evidence for the complete recapitulation
of temporal expression using the Pfpcna flanking
sequences described.
Functional characterization of the Pfpcna promoter
has identified two distal regions that affect promoter
activity, both of which were shown to competitively
bind trans-acting nuclear factors [12,16]. These studies,
whilst able to derive significant differences between the
bioluminescent signals produced from the full-length
and minimal promoter constructs, were, however,
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Figure 2 Optimization of the single-lysis step protocol.( A) The mean ± stdev of RLU normalized for parasite number is compared to the
pellet-volumes of PLB/0.1% saponin lysis buffer. (B) Comparison of the mean ± stdev RLU against total parasite number shows a strong linear
correlation. Bioluminescence was measured from varying volumes of IE pellet supplemented with either PBS (filled circles) or uIE (unfilled circles)
to a total volume of 20 μl.
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promoter construct due to variance in the bioluminesce
signals obtained using the standard promoter assay
employed in that study. Moreover, the preferred analysis
of this type of promoter deletion study would include
samples isolated at different morphological stages to
explore both temporal and absolute changes in promo-
ter function. This multi-variate statistical analysis, how-
ever, requires a ready method to assay multiple samples
and consistent datasets. In an attempt to show whether
the single-step lysis protocol could establish significance
in such a study, all three parasite clones (Pfluc, Δ2a n d
Δ3 [12]) used in the previous study were tightly syn-
chronized to ring stage parasites and the bioluminescent
signals monitored at ring (six-14 hours post-infection,
hpi), early trophozoite (18-24 hpi), late trophozoites/
schizont (30-36 hpi) and schizont/reinvaded rings (42-
two hpi) stages. As expected, the peak of biolumines-
cence in all clones occurs in the mature trophozoite/
schizont stage as these promoter deletions do not
appear to affect the temporal activity of the Pfpcna pro-
moter, only its absolute activity (Figure 4). And, as
expected, as additional functional components of the
promoter region are deleted, there is a contempora-
neous decrease in luciferase activity. However, using the
improved consistency in bioluminescent signals mea-
sured here, significant differences could be established
between the absolute activity of the different promoter
constructs in both the early trophozoite and late tropho-
zoite/schizont time points (p < 0.001). Whilst compari-
sons in the other samples were not significant, this
presumably results from what appears to be the very
low, probably background, bioluminescent signals at
these time points.
Conclusion
Here a revised luciferase reporter gene assay protocol is
described, based on the use of a single lysis-step, which
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Figure 3 Temporal regulation of the Pfpcna promoter during intraerythrocytic development. Starting from an early ring stage culture (c.
3-6 hpi), samples were removed periodically over a 51-hour period and the bioluminescent signal normalized for parasite number measured.
Images from Giemsa-stained thin smears of the time points investigated are shown to demonstrate the major morphological stages present. The
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log-fold up (red) and down (green) accumulation of the steady state transcript level.
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a more consistent bioluminescent signal. Reduction in
the bioluminescent signal due to the presence of haemo-
globin does not affect the specificity of the assay, and
this loss in signal can be ameliorated using a saponin-
supplementation of a commercial buffer. The utility of
this revised assay in typical studies that examine the
absolute and temporal properties of P. falciparum pro-
moters is demonstrated. It is anticipated, however, that
this protocol could be more widely applied to biolumi-
nescence reporter gene assays in other intraerythroctytic
pathogens.
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